PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 189 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,081,000 | -42.7% | 67,799 | +25.3% | 0.00% | -50.0% |
| Q3 2016 | $3,629,000 | +776.6% | 54,120 | +289.2% | 0.00% | – |
| Q2 2016 | $414,000 | +18.6% | 13,906 | +17.0% | 0.00% | – |
| Q1 2016 | $349,000 | -62.6% | 11,882 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $932,000 | -64.2% | 11,882 | -65.6% | 0.00% | -66.7% |
| Q3 2015 | $2,605,000 | -81.9% | 34,574 | -72.0% | 0.00% | -80.0% |
| Q2 2015 | $14,393,000 | -64.5% | 123,277 | -28.2% | 0.02% | -63.4% |
| Q1 2015 | $40,514,000 | +2.0% | 171,589 | -18.2% | 0.04% | +2.5% |
| Q4 2014 | $39,714,000 | -28.0% | 209,825 | -9.3% | 0.04% | -27.3% |
| Q3 2014 | $55,169,000 | +189.0% | 231,246 | -20.1% | 0.06% | +205.6% |
| Q2 2014 | $19,092,000 | -39.8% | 289,260 | -5.1% | 0.02% | -41.9% |
| Q1 2014 | $31,737,000 | +82.6% | 304,755 | +81.5% | 0.03% | +82.4% |
| Q4 2013 | $17,384,000 | +6.3% | 167,915 | -44.9% | 0.02% | +6.2% |
| Q3 2013 | $16,347,000 | -35.2% | 304,641 | -46.4% | 0.02% | -38.5% |
| Q2 2013 | $25,239,000 | – | 568,840 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |